US-NJ, Director - Global Indication Lead - Skin Cancer 219398BR-MZ
Director - Global Indication Lead - Skin Cancer
East Hanover, NJ
The Global Indication Lead (GIL) Melanoma is responsible for developing and implementation of commercial strategy and tactics for Tafinlar+Mekinist (T+M) in metastatic melanoma (MM) in a highly competitive environment with multiple competitors in Targeted Therapies and Immuno-Oncology classes, launching simultaneously.
Lead and implement global T+M MM marketing strategy and tactics to achieve optimal performance in terms of market share and product performance
Partner with Market Access and Medical Affairs teams the cross functional effort to optimize the global long term disease area strategy (DAS) and the short-mid term strategy co-created with countries and regions (IDAPS)
Support launch excellence in collaboration with global/regional/country marketing teams to continue the ongoing launch
Build relationships with global MM medical experts and leverage the insights collected to support launch plan and lifecycle management activities
Identify and showcase MM team global/region/country market penetration efforts through: sharing of key learnings, insights, experiences, and best practices
Ensure global T+M MM A&P budgets and resources are effectively managed within agreed upon limits and plans are effectively implemented
Provide guidance for the MM forecast
Responsible for the commercial interpretation and internal education of key market events within the Oncology organization (e.g. Senior management, IR, etc.)
Key performance indicators/ Measures of success
Empower country teams through global marketing direction and adoption of tools to exceed sales performance goals for T+M MM within a disease area
Measurements of T+M MM profitability, sales vs. budget, market share and market share growth for defined compound(s)
Feedback from regions and countries on collaboration, level of service and quality of coordination/communication related to global/regional/country operating model
Feedback from MM IDAPS and extended teams on collaboration, quality and timing of global deliverables and support to help maximize the disease indications and indications globally
Provide strategic leadership to successfully drive sales growth for approved indications as well as contribute to the development of strategy for future formulations and indications globally.
The Novartis Group of Companies are Equal Opportunity Employers and take pride in maintaining a diverse environment. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
University degree in Marketing, Medicine, Natural or Pharmaceutical Sciences. An advanced degree in science and/or business preferred (e.g., MD, Pharm. D., PhD., MBA)
At least 5 years of healthcare operational marketing / product management or related experience (including country-level product management) oncology experience preferred
Launch experience with new products or major line extensions oncology preferred, multi-country or large market strongly preferred
Pharmaceutical sales experience preferred
Demonstrated ability to engage effectively with global Oncology/Hematology Medical Experts
Comfortable rapidly switching between complex science and commercial concepts, with an ability to bridge between them, build common understanding amongst colleagues with either background
Proven ability to collaborate, operate and influence cross-functionally and cross-culturally in global team
Strong analytical, strategic thinking and project management skills
Strong verbal and written communication skills
25% travel requirement
* If a direct employer requests that you go to their web site and complete your application there in order to be
considered, please do so. Applications for all positions are subject to each employer's specific requirements.